EYEVANCE PHARMACEUTICALS
Dead / Cancelled — Cancelled — Section 8 (as of 06 Feb 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87584990
- Registration number
- 5814137
- Mark type
- Stylized text
- Filed
- 26 Aug 2017
- Published for opposition
- 09 Jan 2018
- Registered
- 23 Jul 2019
- Attorney of record
- Laila S. Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the field of ophthalmology
Owner
- HARROW IP, LLC, NASHVILLE, TN, US
- EYEVANCE PHARMACEUTICALS LLC, Nashville, TN, US
- Eyevance Holdings LLC, Alpharetta, GA, US
- Eyevance Holdings LLC, Alpharetta, GA, US
- Eyevance Holdings LLC, Alpharetta, GA, US
Prosecution history
- 06 Feb 2026 — CANCELLED SEC. 8 (6-YR)
- 23 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Aug 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 09 Aug 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 08 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Sept 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jun 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Jun 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Jun 2019 — USE AMENDMENT FILED